Showing results (411-420 of 502) with videos related to

Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2021
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III StudySuresh S Ramalingam, Silvia Novello, Salih Zeki Guclu, et al.
JAMA Oncology|October 14, 2021
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical TrialCaicun Zhou, Suresh S Ramalingam, Tae Min Kim, et al.
Cancer|January 10, 2018
Health care disparities among octogenarians and nonagenarians with stage III lung cancerRichard J Cassidy, Xinyan Zhang, Jeffrey M Switchenko, et al.
JTO Clinical and Research Reports|May 31, 2022
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional ExperienceA J Piper-Vallillo, Julia K Rotow, Jacqueline V Aredo, et al.
Nature|March 26, 2026
Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustionChristopher B Medina, Ewelina Sobierajska, Minghao Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 BlockadeAnnapaola Mariniello, Tahseen H Nasti, Daniel Y Chang, et al.
Cancer|June 14, 2017
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapyRichard J Cassidy, Xinyan Zhang, Pretesh R Patel, et al.
Clinical Lung Cancer|November 22, 2020
A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)Saiama N Waqar, Mary W Redman, Susanne M Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
The New England Journal of Medicine|April 30, 2015
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancerPasi A Jänne, James Chih-Hsin Yang, Dong-Wan Kim, et al.
Pageof 51